In a nutshell The aim of this study was to evaluate the effects of ginger consumption on blood glucose levels in patients with type 2 diabetes (T2D). The main finding of the study was that patients who consumed ginger had improved blood sugar control. Some background Ginger is a non-toxic spice that is considered safe by the FDA. Some studies have...
Read More
In a nutshell The aim of this study was to investigate the risk of metabolic syndrome after pregnancy in women that had gestational diabetes (GD). The main finding of the study was women who had GD had a higher risk of metabolic syndrome after pregnancy. Some background Insulin is the hormone that controls blood sugar. During pregnancy, women...
Read More
In a nutshell The aim of this study was to identify the risk factors for diabetic eye disease (retinopathy) in patients with type 1 diabetes (T1D). The main finding of the study was that poor blood sugar control, high levels of protein in the urine and high blood pressure were risk factors for diabetic retinopathy (DR) in T1D. Some background There...
Read MoreIn a nutshell The aim of this study was to compare the effects of adding semaglutide versus sitagliptin onto metformin with or without a sulfonylurea in type 2 diabetes (T2D). The main finding was that adding 7mg or 14mg semaglutide on to metformin/sulphonylurea therapy showed greater improvements in blood sugar control compared to sitagliptin. Some...
Read More
In a nutshell The aim of this study was to examine the safety and effectiveness of adding semaglutide to SGLT-2 therapy in type 2 diabetes (T2D). The main finding of the study was that adding semaglutide to SGLT-2 therapy significantly improved blood sugar control and decreased body weight in patients with T2D. Some background There are many different...
Read MoreIn a nutshell The aim of this study was to investigate blood glucose control and rates of hypoglycemia (dangerously low blood glucose levels) when diabetic patients were switched from their basal insulin to insulin degludec (Tresiba). The main finding of this study was that patients who were switched to insulin degludec had improved blood glucose control...
Read MoreIn a nutshell The aim of this study was to compare the cost-effectiveness of semaglutide (Ozempic) to extended-release (ER) exenatide (Byetta, Bydureon) and dulaglutide (Trulicity) ?in the treatment of type 2 diabetes (T2D). The main finding of the study was that once-weekly semaglutide was more cost-effective than exenatide and...
Read More
In a nutshell The aim of this study was to investigate the association between uric acid levels and the risk of heart and kidney disease in type 1 diabetes (T1D). The main finding was that patients with high uric acid levels had a higher risk of kidney disease, heart attacks, strokes, and death. Some background Uric acid (UA) is a substance...
Read More
In a nutshell This trial is examining the safety and effectiveness of new dressing ALLO-ASC-SHEET in the treatment of diabetic foot ulcers. The main outcome to be measured will be the number of patients with completely healed ulcers. This trial is recruiting in California, the United States. The details Diabetic foot ulcers (DFU) are a common...
Read More
In a nutshell This trial is examining the safety and effectiveness of the new drug LMB763 in the treatment of diabetic kidney disease. The main outcome to be measured will be a change in kidney function. This study is being conducted in Florida and Oklahoma, the United States. The details Diabetic kidney disease is a common complication of...
Read More
In a nutshell This trial is examining the safety and effectiveness of relamorelin on diabetic gastroparesis (slowed digestion in diabetic patients). The main outcome to be measured will be the percentage of patients with gastroparesis symptoms. The details High blood glucose levels in diabetes can cause nerves to not work properly. When the nerve...
Read MoreIn a nutshell This trial is examining the effectiveness of a dual-hormone (insulin and glucagon) pump compared to insulin only pump and a predictive low glucose management (PLGM) system in patients with type 1 diabetes (T1D). The main outcome to be measured will be the percentage of time spent with a blood glucose less than 70mg/dl. This study is being...
Read More
